CalScreener® – an innovative device for Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time

Información del proyecto

BADGER

Identificador del acuerdo de subvención: 784514

DOI 10.3030/784514

Proyecto cerrado

Fecha de la firma de la CE 17 Noviembre 2017

Fecha de inicio 1 Diciembre 2017

Fecha de finalización 31 Julio 2020

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total € 3 572 567,50

Aportación de la UE € 3 572 567,50

Coordinado por

SYMCEL AB
Sweden

Resultado final

Documents, reports (4)

Ethics approval for Clinical study no. 3

D 4.1. Ethics approval for Clinical study no. 3 [M20], Deliverable type: R

Scientific paper on the results of Clinical study no.1

D 2.2. Scientific paper on the results of Clinical study no.1 [M5], Deliverable type: R

Ethics approval for Clinical study no. 2

D 3.1. Ethics approval for Clinical study no. 2 [M5], Deliverable type: R

Ethics approval for Clinical study no. 1

D 2.1. Ethics approval for Clinical study no. 1 [M1], Deliverable type: R

Websites, patent fillings, videos etc. (1)

Project subpage on corporate website

D 5.1: Project subpage on corporate website [M3], Deliverable type: DEC

Publicaciones

Peer reviewed articles (1)

Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study

Autores: C. Tellapragada, B. Hasan, A. Antonelli, A. Maruri, C. de Vogel, D. Gijón, M. Coppi, A. Verbon, W. van Wamel, G.M. Rossolini, R. Cantón, C.G. Giske
Publicado en: Clinical Microbiology and Infection, 2020, ISSN 1198-743X
Editor: Blackwell Publishing Inc.
DOI: 10.1016/j.cmi.2020.01.026